AMA: Administration Decision on Medicare Part D Will Benefit Patients

| 1 Min Read

Statement attributed to:

Barbara L. McAneny, M.D.

President, American Medical Association

“Seriously ill patients who faced the prospect of new hurdles to accessing their medication can breathe a sigh of relief now that the Trump administration has discarded the proposal. The American Medical Association commends the administration for recognizing its proposal to weaken coverage for six protected drug classes under Medicare Part D had potential dangers for patient health. The AMA and other patient champions detailed the potential effects of the policy, and we’re grateful the administration listened.

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Smiling woman sits on couch while typing on laptop

Medicare telehealth coverage renewed for two years

| 5 Min Read
Hand stacking blocks with health care icons

3.1% bonus revived for physicians participating in Medicare APMs

| 5 Min Read
Smiling caregiver embraces older smiling patient

Lawmakers extend CMS hospital-at-home waiver for five years

| 4 Min Read
Hand holds smartphone

AMA expert says what to do—and not do—when measuring doctor burnout

| 12 Min Read